Vanderbilt researchers show that two factors promote the repair of myelin, the nerve cell covering that deteriorates in diseases such as multiple sclerosis.

Vanderbilt researchers show that a certain factor negatively impacts the first-line responder cells in the lungs, providing one explanation for why patients with asthma are at greater risk for invasive bacterial disease.

A new biological therapy, ustekinumab, improves markers of disease activity in patients with severe Crohn’s disease.

The hormone leptin regulates glucose balance, but not fat stores, in zebrafish.

Melanoma-specific expression of a certain protein identifies tumors that are more responsive to an immune therapy.

Joseph Coyle, M.D., an expert in the neurobiology of serious mental illness, will deliver the next Flexner Discovery Lecture on Thursday, March 10.